AMGN

Amgen
AMGN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$158.74B
EV
$207.31B
Shares Outstanding
539.09M
Beta
0.50

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$314.70
P/E 2025E
14.17x
P/Revenue 2025E
4.50x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amgen Inc.

gainify
AMGN

Amgen Inc.

AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque ps...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bradway, Robert

Employees

28,000

IPO Date

1983-06-17

Headquarters

One Amgen Center Drive, Thousand Oaks, California, 91320-1799, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.